OmniversalisDAO

OmniversalisDAO Aggregator serves as the gateway connecting #DeSci, #DeTrade, and #DeInvest. Leveraging tools like #blockchain, #AI, and #VR / #AR, OmniversalisDAO revolutionizes #lifesciences & #healthcare but also #trade & #investment. Our platform unites diverse DAOs, including our own, through a #CrossChain Protocole , enabling seamless communication, efficient transactions, and innovative solutions across multiple sectors. Utilizing advanced #WEB3 governance frameworks, we create a cohesive and efficient decentralized ecosystem. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Caroline Rodriguez Samuel Craft Raphael Wenninger Omniversalis Impact Fund Omniversalis Sirrena TeslaDuo Research Trade Pharma Network (TPN) #Innovation #Governance #DecentralizedEcosystem

I’m #hiring. Know anyone who might be interested? 👋😊

🌐 At OmniversalisDAO, we’re proud to sponsor and integrate OmiTwin as a core system in our mission to shape the future of decentralized, sustainable solutions. 🚀 This innovation aligns perfectly with our vision of empowerment, adaptability, and progress. 👏 Kudos to the creators for this inspiring step forward! #OmniversalisDAO #Sustainability #TechForTomorrow

📣 We just published our latest article "DAOs and Level 5 Leadership: Fusing Decentralization with Ethical Excellence" 🌐✨💡 Discover how OmniversalisDAO, enhanced by OmniTwin, is setting new standards for governance, innovation, and collaboration by merging blockchain-driven decentralization with the timeless principles of Level 5 Leadership. This fusion creates resilient, ethical, and visionary DAOs, redefining leadership for a sustainable future. 🚀 Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger SirrenaAI Omniversalis Impact Fund OmniTwin #DAOs #Blockchain #Leadership #Ethics #Innovation #AI #LifeSciences #FutureTech

This development serves as a sobering reminder of the global threat posed by emerging infectious diseases like #MPOX. At TheraVac Biotech, we’re fully aware of the situation and working tirelessly to address it. 🚨 One #MPOX vaccine in our pipeline is TheraVac-MPOX-1: a novel biologic targeting two of the most promising genes/proteins among the six involved in MPOX pathogenesis, including #Clade1b. These proteins are critical to the virus's ability to infect host cells, expand its host range, and evade the immune system—making them prime candidates for therapeutic interventions. 🧬💉 As we advance this and other cutting-edge research projects, we remain committed to accelerating innovative solutions to combat global health threats. Together, we can build a more resilient future. 🌍🔬 Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #LifeScience #TheraVacBiotech #InSilico #AIinHealthcare #GlobalHealth #VaccineDevelopment #PeptideVaccine #Vaccine #PrecisionMedicine #Immunotherapy

Welcome to OmniTwin’s LinkedIn! We're here to transform industries through digital twins, advanced AI, and cutting-edge simulations. Let’s shape the future together—one twin at a time! 🌍✨ Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger TheraVac Biotech TeslaDuo Research SirrenaAI TradePharma Network TradePharmaDAO Omniversalis Impact Fund #AI #Decentralization #DigitalIdentity #DigitalTwins #CredentialingProcess #TechInnovation #Collaboration #Blockchain #Web3 #OmniTwin #OmniComm

🚀 In Progress: NeoVax Development for High-Impact Cancer Neoantigens 🚀 We're excited to share updates on the ongoing progress with #NeoVax, where we are harnessing top #neoantigen targets in our mission to advance personalized cancer immunotherapy. Below are the neoantigens currently being evaluated for their roles in driving aggressive cancers, with targeted mutation fragments, #HLA #binding data, and associated #cancer types: 1. KRAS (G12V)   - Associated Cancers: Pancreatic, colorectal, non-small cell lung cancer (NSCLC)   - HLA Type: HLA-A*11:01   - Binding Score: 35 nM (Strong Binding) 2. EGFR (L858R)   - Associated Cancers: NSCLC, glioblastoma   - HLA Type: HLA-A*02:01   - Binding Score: 80 nM (Intermediate Binding) 3. BRAF (V600E)   - Associated Cancers: Melanoma, colorectal, thyroid, NSCLC   - HLA Type: HLA-A*11:01   - Binding Score: 15 nM (Strong Binding) 4. HER2 (ERBB2)   - Associated Cancers: Breast, gastric, esophageal cancers   - HLA Type: HLA-A*02:01   - Binding Score: 120 nM (Intermediate Binding) 5. NY-ESO-1   - Associated Cancers: Melanoma, ovarian, lung, synovial sarcoma   - HLA Type: HLA-A*02:01   - Binding Score: 20 nM (Strong Binding) 6. MAGE-A3   - Associated Cancers: Melanoma, head and neck, bladder, lung cancers   - HLA Type: HLA-A*02:01   - Binding Score: 45 nM (Strong Binding) 7. WT1 (Wilms Tumor 1)   - Associated Cancers: Leukemia, ovarian, lung cancers   - HLA Type: HLA-A*02:01   - Binding Score: 30 nM (Strong Binding) 8. GPC3 (Glypican-3)   - Associated Cancers: Hepatocellular carcinoma (HCC), melanoma   - HLA Type: HLA-A*24:02   - Binding Score: 70 nM (Intermediate Binding) Each of these neoantigens shows potential for strong to intermediate binding with key HLA types, enhancing their immunogenicity and paving the way for highly personalized cancer treatments. #NeoVax is dedicated to refining these targets to bring transformative therapies to patients worldwide. Stay tuned as we move forward with innovative partnerships & groundbreaking results! Learn more and join us in shaping the future of precision oncology!🧬💡 Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger TradePharma Network TradePharmaDAO Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #TheraVacBiotech #InSilico #AIinHealthcare #NeoAntigens #PeptideVaccine #PrecisionMedicine

🌍 Exploring UBI & Cryptocurrency: A New Era for Economic & Healthcare Inclusion Universal Basic Income (#UBI) has long been discussed as a way to address income inequality and provide basic financial security for all. With the rise of cryptocurrency, digital assets are now seen as a natural & scalable medium for UBI distribution—thanks to their accessibility, transparency, and global reach. 💡 Comparative Overview of UBI-Driven Cryptocurrencies In our recent analysis, we compared #Worldcoin, #Dogecoin, and #HOPE in the UBI space: - Worldcoin aims for UBI via biometric verification, ensuring unique distribution through advanced iris scanning. - Dogecoin leverages community strength and openness, though it doesn't pursue structured UBI. - $HOPE, however, takes a unique approach: it’s focused specifically on healthcare access through its Omniversalis Basic Income (#OBI) program, using #OmniTwin for privacy-centered ID verification & rewarding health-positive behaviours. 💜 The Unique Value of $HOPE $HOPE’s commitment to healthcare equity and data privacy sets it apart. By directly supporting underserved communities through a healthcare-focused UBI model, $HOPE ensures that its humanitarian mission aligns with impactful, real-world outcomes. 🚀 Future Implications As these UBI models evolve, they hold transformative potential for global economic inclusion and healthcare access, potentially reshaping how we address critical challenges worldwide. 🔗 To learn more about how $HOPE is pioneering a blend of economic and healthcare inclusion, stay tuned for our detailed article! Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Caroline Rodriguez Sirrena Caelis Samuel Craft Raphael Wenninger OmniversalisDAO Omniversalis Omniversalis Impact Fund TradePharma Network TradePharmaDAO SirrenaAI #DiplomaticHealthcare #DiplomacyForHealth #Blockchain #Innovation #BlockchainInnovation #HealthcareForAll #InclusionMatters #HumanitarianInnovation #HealthcareEquity #GlobalHealthcare #DAO #SmartContracts #CryptoForGood #HealthcareForAll #FutureOfFinance #MSi

PAMA was honored to participate in the 2024 WHO EMT Global Meeting in Abu Dhabi this week. Our Director of Programs, Sarah Elghalban, addressed the critical session on “Complex Humanitarian Emergencies,” focusing on “Supporting Essential Health Services in Gaza Using Specialized Care Teams”. Sarah detailed the significant access challenges and innovative solutions in deploying MHPSS for healthcare workers in Gaza. She emphasized the vital role of international NGOs in enhancing the effectiveness of Emergency Medical Teams (EMTs) in complex crises. PAMA is committed to advancing healthcare and humanitarian response through innovation and continued collaboration with the WHO and International and local partners.

🚀 Announcing NeoVax®: Pioneering Personalized Cancer Vaccines for the Future of Precision Medicine! 🚀 At #Genovate® Platform, we're thrilled to unveil #NeoVax®, a revolutionary module within TheraVac Biotech, focused on transforming cancer treatment through personalized neoantigen vaccines✨🌐 Why NeoVax®? NeoVax taps into the cutting-edge of immunotherapy by targeting unique mutations (neoantigens) in cancer cells, creating tailor-made vaccines designed to trigger a powerful immune response. Our precision-driven approach identifies, optimizes, and validates the most immunogenic fragments, offering new hope in the fight against aggressive cancers. How It Works NeoVax leverages AI-powered platforms for: 1- Neoantigen Identification & Selection - Harnessing Genovate’s data resources to pinpoint high-potential neoantigen targets. 2- Peptide Synthesis & Optimization - Utilizing molecular docking, MD simulations, and ADMET profiling to refine peptide designs. 3- Vaccine Formulation & Validation - Formulating vaccines through in silico and preclinical trials, moving towards clinical and regulatory milestones with high success projections. Seamless Collaboration & Compliance Integrated with the Genovate ecosystem, NeoVax bridges R&D with regulatory workflows through decentralized, transparent digital twins, ensuring compliance, data integrity, and accelerated approval processes. The Future of Cancer Treatment is Here NeoVax embodies a vision where precision medicine is accessible, tailored, and impactful for every patient. Together with our partners and the wider community, we’re bringing personalized cancer vaccines from concept to clinic. Stay tuned as we move forward with clinical trials, innovative partnerships, and groundbreaking results! Learn more and join us in shaping the future of precision oncology!🧬💡 Dr. Isaad Sainkoudje Marie N. Mendez-Sainkoudje Sirrena Caelis Caroline Rodriguez Samuel Craft Raphael Wenninger TradePharma Network TradePharmaDAO Omniversalis Impact Fund BayesLearn Systems SirrenaAI OmniversalisDAO #Innovation #RnD #Biotech #TheraVacBiotech #InSilico #AIinHealthcare #RegulatoryCompliance #Biologics #NeoAntigens #PreclinicalTrials #ClinicalTrials #PrecisionMedicine #OmniComm #OmniTwin